Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Odds

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Sabouraudia|July 1, 1975
Resistance of the Candida albicans filamentous cycle to environmental changeE G Evans, F C Odds, K T Holland
Archives of Disease in Childhood|January 1, 1992
Candida strains from neonates in a special care baby unitA M Sharp, F C Odds, E G Evans
Sabouraudia|December 1, 1985
Suppression of ATP in Candida albicans by imidazole and derivative antifungal agentsF C Odds, S L Cheesman, A B Abbott
Journal of Biological Standardization|July 1, 1983
Standardization of antigens from Aspergillus fumigatusF C Odds, M D Ryan, P H Sneath
Science (New York, N.Y.)|August 5, 2000
Candida's arranged marriageN A Gow, A J Brown, F C Odds
Trends in Microbiology|January 19, 2000
Might Candida albicans be made to mate after all?F C Odds, A J Brown, N A Gow
The Journal of Antimicrobial Chemotherapy|August 1, 1984
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agentsF C Odds, C E Webster, A B Abbott
The Journal of Antimicrobial Chemotherapy|October 1, 1986
Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitroF C Odds, S L Cheesman, A B Abbott
Chemotherapy|January 1, 1985
Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis modelA Polak, F C Odds, E Lüdin, et al.
Journal of Medical Microbiology|May 1, 1987
Disseminated Candida infection syndrome in heroin addicts--dominance of a single Candida albicans biotypeF C Odds, A Palacio-Hernanz, J Cuadra, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Sabouraudia|July 1, 1975
Resistance of the Candida albicans filamentous cycle to environmental changeE G Evans, F C Odds, K T Holland
Archives of Disease in Childhood|January 1, 1992
Candida strains from neonates in a special care baby unitA M Sharp, F C Odds, E G Evans
Sabouraudia|December 1, 1985
Suppression of ATP in Candida albicans by imidazole and derivative antifungal agentsF C Odds, S L Cheesman, A B Abbott
Journal of Biological Standardization|July 1, 1983
Standardization of antigens from Aspergillus fumigatusF C Odds, M D Ryan, P H Sneath
Science (New York, N.Y.)|August 5, 2000
Candida's arranged marriageN A Gow, A J Brown, F C Odds
Trends in Microbiology|January 19, 2000
Might Candida albicans be made to mate after all?F C Odds, A J Brown, N A Gow
The Journal of Antimicrobial Chemotherapy|August 1, 1984
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agentsF C Odds, C E Webster, A B Abbott
The Journal of Antimicrobial Chemotherapy|October 1, 1986
Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitroF C Odds, S L Cheesman, A B Abbott
Chemotherapy|January 1, 1985
Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis modelA Polak, F C Odds, E Lüdin, et al.
Journal of Medical Microbiology|May 1, 1987
Disseminated Candida infection syndrome in heroin addicts--dominance of a single Candida albicans biotypeF C Odds, A Palacio-Hernanz, J Cuadra, et al.
Pageof 16